SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-39848"
 

Search: onr:"swepub:oai:DiVA.org:oru-39848" > Electrochemotherapy...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Landström, Fredrik,1966-Örebro universitet,Institutionen för hälsovetenskap och medicin,Örebro University Hospital, Örebro, Sweden (author)

Electrochemotherapy - possible benefits and limitations to its use in the head and neck region

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • 2014-12-15
  • Informa Healthcare,2015
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-39848
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-39848URI
  • https://doi.org/10.3109/00016489.2014.947655DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding agency: Genetronics Inc., San Diego, CA, USA
  • Conclusion: Electrochemotherapy (ECT) is an efficacious treatment. It should, however, be used with some caution in the treatment of head and neck cancer.Objectives: To assess local tumor control, safety, survival, and functional outcome after treatment of cancer in the head and neck region with ECT.Methods: Four patients with primary T2 cancer of the oral cavity or oropharynx and one patient with a metastasis of renal cancer in the masseter muscle were treated with ECT with intratumorally administered bleomycin. Control biopsies were carried out 2 months after treatment. Postoperative radiotherapy was performed based on tumor T-stage and the depth of tumor infiltration. Serious adverse events and treatment malfunctions were recorded. The follow-up time was 24 months for the surviving patients and 20 months overall. The PSS-HN scale was used to assess the functional outcome.Results: No local recurrence was recorded in any patient during the follow-up. However, only one patient was treated with ECT alone. There were four serious adverse events: one nearly lethal bleeding, two cases of osteoradionecrosis, and a fistula. One patient died from distant metastasis. The other patients were tumor-free both locally and overall at 24 months. The median functional outcome in all parameters was worse 1 year after treatment.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Reizenstein, JohanÖrebro University Hospital, Örebro, Sweden (author)
  • Nilsson, ChristerÖrebro University Hospital, Örebro, Sweden (author)
  • von Beckerath, Mathias,1966-Örebro universitet,Institutionen för hälsovetenskap och medicin(Swepub:oru)msvt (author)
  • Löfgren, Lennart,1939-Örebro universitet,Institutionen för hälsovetenskap och medicin(Swepub:oru)ltln (author)
  • Adamsson, Gun-BrittÖrebro University Hospital, Örebro, Sweden (author)
  • Möller, Claes,1950-Örebro universitet,Institutionen för hälsovetenskap och medicin(Swepub:oru)cmr (author)
  • Örebro universitetInstitutionen för hälsovetenskap och medicin (creator_code:org_t)

Related titles

  • In:Acta Oto-Laryngologica: Informa Healthcare135:1, s. 90-950001-64891651-2251

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view